120 related articles for article (PubMed ID: 21826097)
1. Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer.
Darimipourain M; Wang S; Ittmann M; Kwabi-Addo B
Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):279-85. PubMed ID: 21826097
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and aberrant expression of Sprouty1 in human prostate cancer.
Kwabi-Addo B; Ren C; Ittmann M
Epigenetics; 2009 Jan; 4(1):54-61. PubMed ID: 19164898
[TBL] [Abstract][Full Text] [Related]
3. microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.
Jin XL; Sun QS; Liu F; Yang HW; Liu M; Liu HX; Xu W; Jiang YY
J Cell Biochem; 2013 Jul; 114(7):1625-33. PubMed ID: 23355454
[TBL] [Abstract][Full Text] [Related]
4. Sprouty1 inhibits angiogenesis in association with up-regulation of p21 and p27.
Lee S; Bui Nguyen TM; Kovalenko D; Adhikari N; Grindle S; Polster SP; Friesel R; Ramakrishnan S; Hall JL
Mol Cell Biochem; 2010 May; 338(1-2):255-61. PubMed ID: 20054616
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis.
Lu Z; Wang F; Yu P; Wang X; Wang Y; Tang ST; Zhu HQ
Vascul Pharmacol; 2018 Mar; 102():29-36. PubMed ID: 29398368
[TBL] [Abstract][Full Text] [Related]
8. Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis.
Sabatel C; Cornet AM; Tabruyn SP; Malvaux L; Castermans K; Martial JA; Struman I
Mol Cancer; 2010 Sep; 9():231. PubMed ID: 20813052
[TBL] [Abstract][Full Text] [Related]
9. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
10. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.
Eisermann K; Tandon S; Bazarov A; Brett A; Fraizer G; Piontkivska H
BMC Genomics; 2008 Jul; 9():337. PubMed ID: 18631392
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
Chai C; Song LJ; Han SY; Li XQ; Li M
CNS Neurosci Ther; 2018 May; 24(5):369-380. PubMed ID: 29316313
[TBL] [Abstract][Full Text] [Related]
15. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.
Kwabi-Addo B; Wang J; Erdem H; Vaid A; Castro P; Ayala G; Ittmann M
Cancer Res; 2004 Jul; 64(14):4728-35. PubMed ID: 15256439
[TBL] [Abstract][Full Text] [Related]
16. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.
Wang H; Liu W; Black S; Turner O; Daniel JM; Dean-Colomb W; He QP; Davis M; Yates C
Oncotarget; 2016 Feb; 7(5):5677-89. PubMed ID: 26734997
[TBL] [Abstract][Full Text] [Related]
17. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Lnc-Spry1 mediates TGF-β-induced epithelial-mesenchymal transition by transcriptional and posttranscriptional regulatory mechanisms.
Rodríguez-Mateo C; Torres B; Gutiérrez G; Pintor-Toro JA
Cell Death Differ; 2017 May; 24(5):785-797. PubMed ID: 28186499
[TBL] [Abstract][Full Text] [Related]
19. Sprouty1 regulates neuritogenesis and survival of cortical neurons.
Gu X; Su X; Jia C; Lin L; Liu S; Zhang P; Wang X; Jiang X
J Cell Physiol; 2019 Aug; 234(8):12847-12864. PubMed ID: 30569452
[TBL] [Abstract][Full Text] [Related]
20. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.
Schaaf G; Hamdi M; Zwijnenburg D; Lakeman A; Geerts D; Versteeg R; Kool M
Cancer Res; 2010 Jan; 70(2):762-71. PubMed ID: 20068162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
